EX-5.2
Published on October 25, 2013
EXHIBIT 5.2
CONSENT OF OSLER, HOSKIN & HARCOURT LLP
October 25, 2013
Acasti Pharma Inc.
545 Promenade du Centropolis, Suite 100
Laval, Québec H7T 0A3
Dear Ladies and Gentlemen:
| Re: | Registration Statement on Form F-10 of Acasti Pharma Inc. |
We have acted as Canadian counsel to Acasti Pharma Inc. (the Registrant) in connection with the registration statement on Form F-10 (the Registration Statement) filed on October 25, 2013 by the Registrant with the Securities and Exchange Commission under the United States Securities Act of 1933, as amended (the Act). We acknowledge that we are referred to under the headings Enforcement of Civil Liabilities and Legal Matters in the prospectus forming a part of the Registration Statement and we hereby consent to such use of our name in the Registration Statement. In giving this consent, we do not thereby admit that we come within the category of persons whose consent is required by the Act or the rules and regulations promulgated thereunder.
Yours very truly,
/s/ Osler, Hoskin & Harcourt LLP
Osler, Hoskin & Harcourt LLP